The results of diagnostic imaging tests frequently change treatment strategies and impact our understanding of disease processes. Functional imaging (i.e. DCE-MRI, BOLD, DW-MRI and PET/MRI) has significantly evolved during the last decade and has now become an important tool in evaluation of patients with gynecological malignancies. It has an added value in assessment of treatment response and treatment follow-up of malignant gynecologic conditions as it provides physiologic and metabolic information in addition to anatomical detail.
This abstract and the presentation materials are available to members only; a login is required.